Novanta Inc. NOVTU
At closeNov 4, 2026, 4:00 PM EST
After hours · Nov 4, 4:00 PM ET
- YTD
- +10.42%
- 1 year
- +26.22%
- Market cap
- 2.30B
- Revenue (ttm)
- 1.03B
- Profit margin
- 6.00%
- YTD return
- +10.42%
- 1-year return
- +26.22%
- Volume
- 10.22K
- Avg volume
- 37.62K
- Open
- 61.44
- Previous close
- 61.47
- Day's range
- 59.24 – 61.46
- 52-week range
- 47.57 – 76.95
- Beta
- 1.70
- Earnings date
- Nov 9, 2026
3M -3.69 (-5.73%)
Key statistics
- Enterprise value
- 1.89B
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 1.42
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 10.30%
- Free cash flow
- 118.38M
- Total cash
- 718.65M
- Total debt
- 285.60M
- Return on equity
- 5.11%
- Short % of float
- 0.00%
- 50-day average
- 60.65
- 200-day average
- 61.39
Next earnings
Nov 9, 2026
Expected Nov 9, 2026. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 9, 2026 | Sep 30, 2026 | 0.967 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | 0.83 | 0.89 | +0.06 | +7.23% |
| May 11, 2026 | Mar 31, 2026 | 0.777 | 0.81 | +0.03 | +4.25% |
| Feb 23, 2026 | Dec 31, 2025 | 0.88 | 0.91 | +0.03 | +3.41% |
| Nov 3, 2025 | Sep 26, 2025 | 0.817 | 0.87 | +0.05 | +6.49% |
| Aug 5, 2025 | Jun 30, 2025 | 0.733 | 0.76 | +0.03 | +3.68% |
About Novanta Inc.
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
- Sector
- Technology
- Industry
- Scientific & Technical Instruments
- Country
- United States
- Website
- novanta.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on NOVTU — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Aequim Alternative Investments LP | 12.73% | 1,400,000 | 84.99M | Jun 29, 2026 |
| Walleye Capital LLC | 11.27% | 1,240,000 | 75.28M | Jun 29, 2026 |
| T. Rowe Price Investment Management, Inc. | 10.87% | 1,195,216 | 72.56M | Jun 29, 2026 |
| Blackrock Inc. | 7.08% | 778,573 | 47.27M | Jun 29, 2026 |
| Two Sigma Investments, LP | 6.62% | 728,371 | 44.22M | Jun 29, 2026 |
| Wolverine Asset Management, LLC | 6.58% | 723,361 | 43.92M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Preferred and Income Securities ETF | 6.97% | 766,773 | 46.55M | Sep 29, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 4.83% | 530,964 | 32.23M | Jun 29, 2026 |
| VanEck ETF Trust-VanEck Preferred Securities ex Financials ETF | 2.92% | 321,086 | 19.49M | Sep 29, 2026 |
| T. Rowe Price Eqy. Fd.s, Inc.-T. Rowe Price Inst. Small-Cap Stock Fd. | 2.63% | 289,539 | 17.58M | Jun 29, 2026 |
| TR PRICE-Price (T.Rowe) U.S. Small-Cap Core Equity Trust | 2.25% | 247,006 | 15.00M | Jun 29, 2026 |
| GLOBAL X FUNDS-Global X U.S. Preferred ETF | 1.76% | 193,689 | 11.76M | Sep 29, 2026 |